证券代码：300334 证券简称：津膜科技 公告编码：2025-026 天津膜天膜科技股份有限公司 关于2024年度拟不进行利润分配的专项说明公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 天津膜天膜科技股份有限公司（以下简称"公司"）于 2025 年 4 月 18 日召开公司 第五届董事会第四次会议、第五届监事会第二次会议，审议通过了《关于 2024 年度 利润分配预案的议案》，本议案尚需提交公司 2024 年年度股东会审议。现将有关情况 公告如下： 一、2024 年度利润分配预案 经致同会计师事务所（特殊普通合伙）审计，公司 2024 年度实现归属于上市公 司股东的净利润为 1,104.74 万元，母公司实现净利润为 135.41 万元。截至 2024 年 12 月 31 日，公司合并报表未分配利润为-82,104.35万元，母公司未分配利润为-74,167.92 万元。 根据《公司法》、《上市公司监管指引第 3 号——上市公司现金分红》及《公司章 程》等相关规定，鉴于公司 2024 年末累计未分配利润为负，并综合考虑公司实际经 营情况，为保障公司正 ...

Financial Performance - The company's operating revenue for 2024 was CNY 245,942,425.69, representing a 22.04% increase compared to CNY 201,518,867.69 in 2023[22]. - The net profit attributable to shareholders for 2024 was CNY 11,047,411.82, a significant turnaround from a loss of CNY 10,905,749.82 in 2023, marking a 201.30% improvement[22]. - The net cash flow from operating activities improved by 96.50%, reaching CNY -2,690,150.74 in 2024, compared to CNY -76,869,244.58 in 2023[22]. - Basic and diluted earnings per share for 2024 were CNY 0.04, a 200.00% increase from CNY -0.04 in 2023[22]. - The total assets at the end of 2024 were CNY 948,323,357.76, a decrease of 1.72% from CNY 964,954,871.76 at the end of 2023[22]. - The net assets attributable to shareholders increased by 1.80% to CNY 577,416,350.25 at the end of 2024, compared to CNY 567,229,823.90 at the end of 2023[22]. - The company reported a significant reduction in non-recurring losses, with the net profit excluding non-recurring items improving by 38.17% to CNY -21,975,599.19 in 2024 from CNY -35,540,862.14 in 2023[22]. - The weighted average return on net assets for 2024 was 1.93%, a recovery from -1.89% in 2023[22]. Revenue and Sales Trends - The company's total revenue for the first quarter was approximately ¥50.12 million, with a significant increase to ¥82.61 million in the second quarter, followed by a decline to ¥36.20 million in the third quarter, and a recovery to ¥77.01 million in the fourth quarter[25]. - The net profit attributable to shareholders was ¥1.45 million in the first quarter, but the company reported a loss of ¥44,211.15 in the second quarter and a larger loss of ¥13.29 million in the third quarter, before returning to a profit of ¥22.93 million in the fourth quarter[25]. - The net cash flow from operating activities showed a positive figure of ¥10.63 million in the first quarter, but turned negative in the second and third quarters with losses of ¥19.83 million and ¥20.19 million respectively, before rebounding to ¥26.69 million in the fourth quarter[25]. - The company achieved operating revenue of 24,594.24 million yuan, a year-on-year increase of 22.04%, and a comparable revenue growth of 29.68% after excluding the impact of the previous year's sale of a wastewater treatment subsidiary[60]. - The total profit reached 1,203.10 million yuan, reflecting a significant year-on-year growth of 250.04%, while the net profit attributable to shareholders was 1,104.74 million yuan, up 201.30%[60]. - The sales revenue from separation membranes and water treatment equipment increased compared to the same period last year, contributing to the overall revenue growth[61]. Market and Industry Trends - The membrane separation technology is increasingly replacing traditional separation methods in various industries, including pharmaceuticals, food and beverage, and chemicals, highlighting its growing market relevance[34]. - The market for membrane technology is expected to expand due to rising municipal water treatment standards and increasing demand for water conservation, particularly in wastewater treatment and desalination[33]. - The company is focusing on the development of high-performance separation membranes as a key strategic material, supported by national policies recognizing the membrane industry as a strategic emerging industry[36]. - The company has seen a growing application of membrane technology in new energy sectors, including hydrogen separation and fuel cells, indicating a promising market outlook[35]. - The hollow fiber membrane has become the most competitive and widely used type of membrane globally, with applications in various sectors including municipal and industrial water treatment[107]. - The global membrane separation technology industry is rapidly developing, with domestic companies achieving significant advancements in performance and cost-effectiveness[105]. Research and Development - The company plans to increase R&D investment, focusing on new materials and technologies such as wet-process modified PVDF materials and enhanced hollow fiber nanofiltration membranes, which have shown promising results[48]. - The company is focused on developing high-performance, low-cost PVDF hollow fiber membranes for seawater desalination, aiming to enhance market share in membrane applications[80]. - The company is focusing on continuous investment in R&D for new products and technologies, including hollow fiber nanofiltration membranes and semiconductor ultra-pure water filtration products[113]. - Research and development expenses remained stable at 25,398,137.02 yuan, showing a slight decrease of 0.20% compared to the previous year[79]. - The number of R&D personnel increased by 9.57% to 103, with a notable rise in the number of master's degree holders from 9 to 15[80]. Governance and Management - The company has established a governance structure that complies with relevant laws and regulations, including the implementation of a public opinion management system and revisions to its articles of association[130]. - The board of directors consists of 8 members, including 4 independent directors, ensuring compliance with legal and regulatory requirements[133]. - The supervisory board is composed of 3 members, including 1 employee supervisor, fulfilling legal requirements for oversight of financial and operational matters[135]. - The company has a robust information disclosure system, ensuring timely and accurate communication with investors through designated media[136]. - The company has implemented a performance evaluation and incentive mechanism for senior management, aligning with its development status[137]. - The company emphasizes social responsibility and stakeholder engagement, aiming for a balance of interests among shareholders, employees, and society[138]. Environmental and Social Responsibility - The company actively participates in public welfare actions, contributing to water conservation and pollution reduction efforts[196]. - The company implemented measures to reduce carbon emissions, including updating air compressor equipment and optimizing product packaging[194]. - The company has not reported any major environmental issues or administrative penalties during the reporting period[194]. Challenges and Risks - The company is facing risks from intensified industry competition, particularly in the hollow fiber membrane sector, which may lead to price declines[117]. - The company has identified potential risks related to raw material price fluctuations, which could impact product profitability and production capacity[118]. - The company anticipates a challenging market environment in 2025, focusing on strategic goals and operational improvements to drive high-quality development[110]. Employee and Compensation - The total remuneration paid to directors, supervisors, and senior management during the reporting period amounted to 5.7986 million yuan before tax[163]. - The chairman and CEO, Fan Ning, received a total pre-tax remuneration of 898,700 yuan[165]. - The company emphasizes a competitive salary structure combining basic salary, performance pay, and bonuses to motivate employees[182]. - The total number of employees at the end of the reporting period is 361, including 246 from the parent company and 115 from major subsidiaries[181].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 49,506,666.59, a decrease of 1.23% compared to CNY 50,124,898.01 in the same period last year[5] - Net profit attributable to shareholders increased by 19.05% to CNY 1,724,423.28 from CNY 1,448,496.25 year-on-year[5] - The company reported a net profit of 2,030,130.07, an increase of 26.94% compared to the previous period[12] - Operating profit reached 2,545,698.57, reflecting a growth of 123.81% year-over-year[12] - Total profit amounted to 2,587,541.82, which is a 58.16% increase from the last reporting period[12] - Basic and diluted earnings per share improved to CNY 0.0057 from CNY 0.0048, reflecting better profitability[26] Cash Flow and Assets - The net cash flow from operating activities rose significantly by 104.47% to CNY 21,741,899.23 compared to CNY 10,633,328.62 in the previous year[5] - Cash and cash equivalents increased by 28.49% to CNY 113,537,459.01 from CNY 88,362,350.75 at the beginning of the year[11] - The company experienced a significant increase in cash inflows from operating activities, totaling CNY 106,603,827.06 compared to CNY 74,516,259.60 in the previous period[29] - As of March 31, 2025, the total assets of the company amounted to CNY 957,246,282.05, an increase from CNY 948,323,357.76 at the beginning of the period[24] - Accounts receivable decreased by 15.61% to CNY 186,945,861.99 from CNY 221,515,894.00 at the beginning of the year[11] Costs and Expenses - The company reported a gross profit margin of 36.73%, an increase of 7.17 percentage points from the previous year, driven by a decrease in raw material prices[9] - Total operating costs increased to CNY 58,300,473.64 from CNY 57,733,809.35, with operating costs specifically rising from CNY 35,303,767.47 to CNY 31,321,004.38[25] - Research and development expenses for the period were CNY 5,747,722.73, a decrease of 5.61% compared to CNY 6,089,171.92 in the previous year[11] - Research and development expenses decreased slightly to CNY 5,747,722.73 from CNY 6,089,171.92, indicating a focus on cost management[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,577[14] - The largest shareholder,航膜科技发展集团有限公司, holds 23.63% of the shares, totaling 71,372,565 shares[14] - The shareholder 华益科技国际 (British Virgin Islands) plans to reduce its stake by up to 3,020,000 shares, representing 1% of the total share capital[19] Corporate Developments - The company appointed Mr. Fan Ning as the General Manager and Mr. Lv Xiaolong as the Chief Scientist during the second meeting of the fifth board of directors[20] - The company completed the internal transfer of membrane production-related assets to its wholly-owned subsidiary Tianjin Membrane Technology Co., Ltd. as of January 1, 2025[21] - The company’s subsidiary, Hebei Jinmo New Materials Technology Co., Ltd., acquired a 34% stake in Shandong Jinmo New Materials Technology Co., Ltd. for a total investment of CNY 10.2 million[21] Legal and Financial Guarantees - A major lawsuit involving the company has progressed, with a court ruling in favor of the company, leading to partial recovery of funds[18] - The company plans to provide guarantees for its wholly-owned subsidiaries to secure additional financing[16] Future Outlook - The company plans to continue enhancing its marketing strategies and accelerate project delivery and payment collection throughout the year[10] - The company has increased its marketing efforts and project implementation, resulting in a good growth in new orders for membrane products and systems[10] Accounting and Reporting - The first quarter report is unaudited[31] - The new accounting standards will be implemented starting in 2025[31] - The financial statement items related to the first year of implementation will be adjusted accordingly[31] - The board of directors announced the report on April 21, 2025[31]

证券代码：300334 证券简称：津膜科技 公告编码：2025-017 天津膜天膜科技股份有限公司 关于公司控股股东参与投资设立膜材料科创基金的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 控股股东参与投资设立基金情况概述 2024年11月7日，天津膜天膜科技股份有限公司（以下简称"公司"）召开了第四届董 事会第二十七次会议、第四届监事会第十三次会议，审议通过《关于同意公司控股股东参 与投资设立膜材料科创基金的议案》。2024年11月25日，公司召开了2024年第三次临时股东 大会，审议通过《关于同意公司控股股东参与投资设立膜材料科创基金的议案》。 基金名称：沧州膜先进材料京津冀创业投资基金（有限合伙） 管理人名称：北京航科君富私募基金管理中心（有限合伙） 1 托管人名称：中国工商银行股份有限公司 备案编码：SAVB36 备案日期：2025年3月13日 三、备查文件 1. 《私募投资基金备案证明》 特此公告。 根据上述董事会、监事会及股东大会决议，公司同意控股股东航膜科技发展集团有限 公司（以下简称"航膜集团"）联合河北省科技金融发展促进中心 ...

第五届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、天津膜天膜科技股份有限公司（以下简称"公司"）第五届董事会第三次 会议通知于 2025 年 2 月 27 日向各位董事以书面方式送达。 2、本次董事会于 2025 年 3 月 6 日以现场与通讯结合方式召开。现场会议地 点：天津经济技术开发区第十一大街 60 号会议室。 3、本次董事会会议应到董事 8 名，实到董事 8 名。（其中：以通讯表决方式 出席会议 7 名）。董事翟军先生、郑春建先生、谢京先生、李春之先生、刘志刚 先生、崔嵘女士、熊文钊先生以通讯方式参加会议并表决。 证券代码：300334 证券简称：津膜科技 公告编码：2025-015 天津膜天膜科技股份有限公司 4、董事长范宁先生作为本次会议的主持人，公司监事会成员施耀华先生、 侯雪征女士、首席科学家吕晓龙先生、副总经理兼投融资总监兼董事会秘书宋辉 鹏先生列席了会议。 5、本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程的规定。 二、董事会会议审议情况 1、审议通过 ...

天津膜天膜科技股份有限公司（以下简称"公司"或"津膜科技"）于 2025 年 3 月 6 日召开了第五届董事会第三次会议，会议以 8 票同意、0 票反对、0 票弃权审议通 过了《关于为全资子公司及孙公司融资提供担保的议案》。现将具体情况公告如下： 一、担保情况概述 公司于 2024 年取得中国建设银行天津开发分行（以下简称"建行"）及建信融通 有限责任公司（以下简称"建信融通"）为期一年的综合授信批复，其中获批的授信方 式包含"e 信通"融资。鉴于公司全资子公司天津膜天膜环境工程有限公司（以下简称 "环境工程"）及全资孙公司天津膜天膜材料科技有限公司（以下简称 "天津膜材 料"）在开展专业化运营中存在实际资金需求，公司向建行及建信融通申请调整授信方 案，具体为：在综合授信额度内，公司及公司的全资/控股子公司、孙公司可根据资金 需求向建行及建信融通申请"e 信通"融资业务，若全资/控股子公司、孙公司提用"e 信通"融资额度，公司须为其开展"e 信通"业务的付款义务承担无条件付款责任，该 付款责任构成实质性担保（一般连带责任保证）。本次提供担保的授信方案如下： （一）环境工程 1.授信类型："e 信通"融资 2. ...

证券代码：300334 证券简称：津膜科技 公告编码：2025-014 天津膜天膜科技股份有限公司 关于参与投资膜材料创业投资母基金暨关联交易的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、与专业投资机构共同投资暨关联交易概述 为加强与公司膜主业领域的产业链、生态圈各方的战略合作与协同，探索和完善公司 在膜主业领域的产业链布局，加强公司核心竞争力，公司于2024年12月27日召开了第四届 董事会第三十次会议，审议通过了《关于拟参与投资膜材料创业投资母基金暨关联交易的 议案》，公司参与投资北京航科君富私募基金管理中心（有限合伙）（以下简称"北京航科"） 发起设立的膜材料京津冀创业投资母基金（有限合伙）（暂定名，经市场监督管理局核准后 名称为天津膜绿色创业投资基金合伙企业（有限合伙））。公司作为有限合伙人以自有资金 对本基金认缴出资3000万元。 具 体 内 容 详 见 公 司 于 2024 年 12 月 30 日 、 2025 年 2 月 7 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于拟参与投资膜 ...

证券代码：300334 证券简称：津膜科技 公告编码：2025-013 天津膜天膜科技股份有限公司 截至本公告披露日，梁峰先生未持有公司股份，不存在应当履行而未履行的承诺事 项。梁峰先生逝世后，公司现任董事会成员由9名变为8名，未低于法定最低人数，但低于 《公司章程》规定的董事会成员人数。公司将根据《公司法》《公司章程》等有关规定， 尽快增补新的董事并及时履行信息披露义务。 特此公告。 天津膜天膜科技股份有限公司董事会 2025 年 3 月 3 日 1 关于非独立董事逝世的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 天津膜天膜科技股份有限公司（以下简称"公司"）董事会沉痛公告，公司第五届 董事会非独立董事梁峰先生因突发疾病，经抢救无效，于2025年3月1日不幸逝世。公司及 董事会对梁峰先生的逝世表示沉痛哀悼，并向其家属致以深切慰问！ 梁峰先生任公司非独立董事，同时兼任公司第五届董事会战略委员会委员、审计委 员会委员、薪酬与考核委员会委员，原定任期至第五届董事会届满。梁峰先生担任公司非 独立董事及专门委员会委员期间恪尽职守、勤勉尽责，以其深厚的专业素养 ...

证券代码：300334 证券简称：津膜科技 公告编码：2025-012 天津膜天膜科技股份有限公司 关于持股5%以上股东减持计划预披露的公告 持股 5%以上股东华益科技国际（英属维尔京群岛）有限公司保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有天津膜天膜科技股份有限公司（以下简称"本公司"或"津膜科技"） 30,852,400 股（占本公司总股本比例 10.21%）的股东华益科技国际（英属维尔京群岛） 有限公司计划在公告之日起十五个交易日后的三个月内以集中竞价方式减持本公司股份 不超过 3,020,000 股（即不超过本公司总股本比例 1%）。 本公司于近日收到华益科技国际（英属维尔京群岛）有限公司（以下简称"华益公 司"）出具的《股东减持计划告知函》，现将有关情况公告如下： 一、股东基本情况 1、减持股东名称：华益科技国际（英属维尔京群岛）有限公司 2、截至本公告日，华益公司持有本公司股份 30,852,400 股，占本公司总股本的 10.21%。 1、拟减持原因：华益公司经营需要。 2 ...

证券时报网讯，新年伊始，津膜科技董事长总经理范宁率公司研发、市场、战略合作等负责人员赴自然 资源部天津海水淡化与综合利用研究所（简称海淡所）举行全面深化合作对接交流会。 双方围绕海水淡化产业发展，从材料、产品、技术装备、工艺应用到科研对接、平台共享、人才合作等 多方面展开深入交流，共商合作发展大计，达成诸多共识。 ...